ALLISON FRY: Open Payments
NPI 1407215809 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 5 payments from 4 companies in 2025. Trend: 2023 $577 · 2024 $356 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $143 |
| ABBVIE INC. | 1 | $105 |
| Neurocrine BioSciences, Inc. | 1 | $96 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: ABILIFY MAINTENA, VRAYLAR, INGREZZA, ABILIFY ASIMTUFII, COBENFY.
Industry payments across NV — which companies pay providers there.
